Do bioprosthetic aortic valves deteriorate more rapidly in patients with the metabolic syndrome?: Commentary

Nature Clinical Practice Cardiovascular Medicine

Volumn 4, Issue 4, 2007, Pages 192-193

  O'Brien, Kevin D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN SENSITIZING AGENT; TRIACYLGLYCEROL;

AORTA VALVE DISEASE; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ATHEROSCLEROSIS; BIOPROSTHESIS; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL CALCIFICATION; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DOPPLER ECHOCARDIOGRAPHY; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEMODYNAMICS; HIGH RISK POPULATION; HUMAN; KIDNEY FAILURE; KINESIOTHERAPY; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTHESIS FAILURE; RETROSPECTIVE STUDY; SHORT SURVEY; SURGICAL RISK; TRIACYLGLYCEROL BLOOD LEVEL; UNIVARIATE ANALYSIS; WEIGHT REDUCTION;

EID: 34047128120     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio0826     Document Type: Short Survey

References (6)

1. O'Brien KD (2006) Pathogenesis of calcific aortic valve disease: A disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol 26: 1721-1728
2. Bonow RO et al. (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Developed in collaboration with the Society of Cardiovascular Anesthesiologists
3. Cowell SJ et al. for the Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators (2005) A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 352: 2389-2397
4. Eckel RH et al. (2005) The metabolic syndrome. Lancet 365: 1415-1428
5. Katz R et al. (2006) Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation 113: 2113-2119
6. Briand M et al. (2006) Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J Am Coll Cardiol 47:2229-2236